MSGV1-1D3-28Z.1-3 mut Citations (4)

Originally described in: Adoptive transfer of syngeneic T cells transduced with a chimeric antigen receptor that recognizes murine CD19 can eradicate lymphoma and normal B cells.
Kochenderfer JN, Yu Z, Frasheri D, Restifo NP, Rosenberg SA Blood. 2010 Nov 11;116(19):3875-86. doi: 10.1182/blood-2010-01-265041. Epub 2010 Jul 14. PubMed Journal

---

Articles Citing MSGV1-1D3-28Z.1-3 mut

Articles
Next Generation Sequencing-Based Identification of T-Cell Receptors for Immunotherapy Against Hepatocellular Carcinoma. Ma Y, Ou J, Lin T, Chen L, Chen J, Wang M. Hepatol Commun. 2021 Feb 28;5(6):1106-1119. doi: 10.1002/hep4.1697. eCollection 2021 Jun. PubMed
Nano-optogenetic engineering of CAR T cells for precision immunotherapy with enhanced safety. Nguyen NT, Huang K, Zeng H, Jing J, Wang R, Fang S, Chen J, Liu X, Huang Z, You MJ, Rao A, Huang Y, Han G, Zhou Y. Nat Nanotechnol. 2021 Dec;16(12):1424-1434. doi: 10.1038/s41565-021-00982-5. Epub 2021 Oct 25. PubMed
Repolarization of Tumor-Infiltrating Myeloid Cells for Augmentation of CAR T Cell Therapies. Luo W, Napoleon JV, Zhang F, Lee YG, Wang B, Putt KS, Low PS. Front Immunol. 2022 Feb 16;13:816761. doi: 10.3389/fimmu.2022.816761. eCollection 2022. PubMed
Identification and assessment of TCR-T cells targeting an epitope conserved in SARS-CoV-2 variants for the treatment of COVID-19. Ma Y, Liu F, Li B, Peng K, Zhou H, Xu Y, Qiao D, Deng L, Tian G, Nielsen M, Wang M. Int Immunopharmacol. 2022 Nov;112:109283. doi: 10.1016/j.intimp.2022.109283. Epub 2022 Sep 28. PubMed

If you have published an article using this material, please email us at to have your article added to this page.